Heart Podcast
Diagnosis and management of resistant hypertension
Sep 24, 2024
Dr. Miguel Camafort, a specialist in resistant hypertension from Barcelona, shares his expertise on tackling this challenging condition. He emphasizes the differences in diagnosis and management standards between American and European practices. The conversation dives into the importance of patient adherence and lifestyle changes as essential components of effective treatment. Dr. Camafort also discusses innovative therapies, including renal denervation, and highlights new drug developments that could shape future management strategies.
20:04
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Accurately diagnosing resistant hypertension involves differentiating true cases from pseudoresistance through thorough assessment and out-of-office blood pressure measurements.
- Emerging therapies like endothelin receptor agonists and renal denervation therapy illustrate innovative approaches being explored for managing resistant hypertension effectively.
Deep dives
Understanding Resistant Hypertension
Resistant hypertension is defined as hypertension that persists despite treatment with three different antihypertensive medications. Guidelines differ internationally, with European criteria requiring a blood pressure over 140/90 mmHg, while American guidelines set the threshold at 130/80 mmHg. Notably, the inclusion of patients requiring four medications for control can suggest resistant hypertension in the American guidelines, expanding the definition's scope. Accurately identifying this condition is crucial, as it correlates significantly with increased risks of hypertension-mediated organ damage and cardiovascular events.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
